|
|
||||||||
Published online before print January 13, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
1 and
2 integrins
,
,
,
Departments of *Experimental Immunohematology and
Molecular Cell Biology, Sanquin Research at CLB and Landsteiner Laboratory, Academic Medical Center, Amsterdam, The Netherlands; and
Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, The Netherlands
| Abstract |
|---|
Human monocytes adhere to activated platelets, resulting in the formation of platelet-monocyte complexes (PMC). Complex formation depends on the interaction between platelet-displayed P-selectin and the specific ligand for P-selectin on leukocytes, P-selectin glycoprotein ligand-1 (PSGL-1). We have recently shown that monocytes within a PMC have increased adhesive capacity to the activated endothelium. To better understand the effect of platelet binding on the capacity of monocytes to adhere to activated endothelium, the P-selectin-PSGL-1 interaction-induced changes in integrin functionality were studied. The binding of platelets to monocytes via P-selectin-PSGL-1 interactions was shown to increase expression and activity of
4
1 and
M
2 integrin, with a concomitant decrease in L-selectin expression. Furthermore, the binding of platelets to monocytes resulted in increased monocyte adhesion to intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and fibronectin. Platelet binding was also responsible for an increase in monocyte transendothelial migration. Similar effects were observed after engagement of PSGL-1 with specific antibodies or with P-selectin immunoglobulin protein. Our data suggest that platelets, by binding via P-selectin to PSGL-1 on monocytes, induce up-regulation and activation of
1 and
2 integrins and increased adhesion of monocytes to activated endothelium. Hence, monocytes within PMC are in a higher state of activation and may have, therefore, an increased atherogenic capacity.
Key Words: endothelial cells platelet-monocyte complexes cell surface adhesion molecules cell activation
This article has been cited by other articles:
![]() |
H. Xu, A. Manivannan, I. Crane, R. Dawson, and J. Liversidge Critical but divergent roles for CD62L and CD44 in directing blood monocyte trafficking in vivo during inflammation Blood, August 15, 2008; 112(4): 1166 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bournazos, J. Rennie, S. P. Hart, K. A.A. Fox, and I. Dransfield Monocyte Functional Responsiveness After PSGL-1-Mediated Platelet Adhesion Is Dependent on Platelet Activation Status Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1491 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Drewniak, J.-J. Boelens, H. Vrielink, A. T.J. Tool, M. C.A. Bruin, M. van den Heuvel-Eibrink, L. Ball, M. D. van de Wetering, D. Roos, and T. W. Kuijpers Granulocyte concentrates: prolonged functional capacity during storage in the presence of phenotypic changes Haematologica, July 1, 2008; 93(7): 1058 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vowinkel, K. C. Wood, K. Y. Stokes, J. Russell, A. Tailor, C. Anthoni, N. Senninger, C. F. Krieglstein, and D. N. Granger Mechanisms of platelet and leukocyte recruitment in experimental colitis Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G1054 - G1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Haselmayer, L. Grosse-Hovest, P. von Landenberg, H. Schild, and M. P. Radsak TREM-1 ligand expression on platelets enhances neutrophil activation Blood, August 1, 2007; 110(3): 1029 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Koenen, P. von Hundelshausen, and C. Weber Inflammatory Blues Turns Velvet Skin Into Rawhide: Monocyte Rolling on Modified Endothelial PSGL-1 Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 990 - 992. [Full Text] [PDF] |
||||
![]() |
P. von Hundelshausen and C. Weber Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease Circ. Res., January 5, 2007; 100(1): 27 - 40. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |